Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Heatwave
Char Dham Yatra
Gyanvapi Mosque
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / 35 lakh doses of J&J COVID-19 vaccine reach Kasauli lab
India

35 lakh doses of J&J COVID-19 vaccine reach Kasauli lab

35 lakh doses of J&J COVID-19 vaccine reach Kasauli lab
Written by Siddhant Pandey
Sep 15, 2021, 09:40 am 2 min read
35 lakh doses of J&J COVID-19 vaccine reach Kasauli lab
Johnson & Johnson’s COVID-19 vaccine, Janssen, is being manufactured in collaboration with Hyderabad-based Biological E.

Around 35 lakh doses of the COVID-19 vaccine developed by United States pharma giant Johnson & Johnson have reportedly reached the apex vaccine testing laboratory in Kasauli, Himachal Pradesh. The single-shot vaccine, called Janssen, has been found to be 85.4% against severe disease. India had approved the vaccine in August and it is being manufactured in collaboration with Hyderabad-based Biological E.

Details
Vaccine to be tested on 100 participants

An official of the Union Health Ministry told CNN-News18 that 35 lakh doses have been sent to the Kasauli lab in the first batch for testing. "It will take around two to three weeks for testing at CDL (Central Drugs Laboratory)," added the official. Thereafter, the COVID-19 vaccine will be tested on 100 participants for seven days in a fast-tracked model.

Information
'After testing on 100 people, national rollout will be approved'

The official said, "After completing the testing, the vaccine will be administered to 100 participants first, as mentioned in the rules for foreign vaccines. After analyzing those 100 participants for seven days, the regulator will approve the vaccine for national rollout."

Background
Vaccine granted EUA in August; 6 shots approved so far

Earlier, it was reported that Janssen will be rolled out by October. The vaccine had been granted Emergency Use Approval (EUA) by the Drug Controller General of India (DCGI) on August 7, making it the fifth COVID-19 vaccine approved in India. Overall, six vaccines have been approved for use in India so far: Covishield, COVAXIN, Sputnik V, Moderna, Janssen, and Zydus Cadila's ZyCoV-D.

Rules
India had fast-tracked approvals for certain foreign vaccines

The Union Health Ministry had revised its rules on April 13, allowing fast-tracked approval for foreign COVID-19 vaccines that have been granted emergency approval for restricted use by the US-FDA, the EMA, the UK-MHRA, the PMDA-Japan, or the World Health Organization. These vaccines will be granted approval after bridging trials on 100 beneficiaries for seven days instead of full-fledged local clinical trials.

Vaccine
What is the J&J vaccine?

J&J's vaccine uses a single shot, which has a clear advantage in mass vaccinations among hard-to-reach populations, such as homeless people. Janssen—which can be stored at 2-8°C—is 85.4% effective in preventing severe disease and 93.1% effective in preventing hospitalization. Earlier, there had been concerns about a blood clot risk, which had prompted the European Medicines Agency to suggest listing it as a rare side-effect.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Siddhant Pandey
Siddhant Pandey
Twitter
Siddhant Pandey covers national and health news at NewsBytes. He has over five years of experience working as a multimedia journalist covering hard news in New Delhi. He was previously employed with The Indian Express and News World India and has juggled roles as a correspondent, copy editor, and video producer. He holds a Bachelor’s degree in Biotechnology from the Jaypee Institute of Information Technology, Noida.
Latest
Himachal Pradesh
Johnson & Johnson
Coronavirus
COVID-19 Vaccine
Biological E
Related
Latest
'Tezaab': Madhuri Dixit, Anil Kapoor's classic gearing up for remake
'Tezaab': Madhuri Dixit, Anil Kapoor's classic gearing up for remake Entertainment
iQOO Neo 6 to launch in India on May 31
iQOO Neo 6 to launch in India on May 31 Technology
12 killed in salt factory wall collapse in Gujarat's Morbi
12 killed in salt factory wall collapse in Gujarat's Morbi India
Johnny-Amber defamation trial: From poop incident to abusive audio clips
Johnny-Amber defamation trial: From poop incident to abusive audio clips Entertainment
Ahead of launch in India, Jeep Meridian receives 1,200 bookings
Ahead of launch in India, Jeep Meridian receives 1,200 bookings Auto
Himachal Pradesh
Your guide to traveling to Tirthan Valley
Your guide to traveling to Tirthan Valley Lifestyle
Your guide to traveling to Lahaul this summer
Your guide to traveling to Lahaul this summer Lifestyle
5 hot water springs in India promising a mystical trip
5 hot water springs in India promising a mystical trip Lifestyle
Ex-telecom minister Sukh Ram dies at 94; cremation on Thursday
Ex-telecom minister Sukh Ram dies at 94; cremation on Thursday Politics
HP: Interstate borders sealed after Khalistan flags found at Assembly
HP: Interstate borders sealed after Khalistan flags found at Assembly India
More News
Johnson & Johnson
J&J vaccine's 1cr doses ready for export after CDL nod
J&J vaccine's 1cr doses ready for export after CDL nod India
J&J's one-dose COVID-19 vaccine gets the nod in India
J&J's one-dose COVID-19 vaccine gets the nod in India India
J&J applies for EUA of COVID-19 vaccine in India
J&J applies for EUA of COVID-19 vaccine in India India
J&J withdraws vaccine approval request in India, CDSCO says
J&J withdraws vaccine approval request in India, CDSCO says India
FDA adds warning of rare reaction risk to J&J vaccine
FDA adds warning of rare reaction risk to J&J vaccine World
More News
Coronavirus
COVID-19: India logs 3,303 new cases; 39 more deaths
COVID-19: India logs 3,303 new cases; 39 more deaths India
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man India
COVID-19 vaccine precautionary dose available for 18+ from April 10
COVID-19 vaccine precautionary dose available for 18+ from April 10 India
COVID-19 survivors at risk of developing serious blood clots: Study
COVID-19 survivors at risk of developing serious blood clots: Study Technology
COVID-19: India reports 1,660 new cases, 4,100 more deaths
COVID-19: India reports 1,660 new cases, 4,100 more deaths India
More News
COVID-19 Vaccine
North Korea confirms first COVID-19 case ever, imposes nationwide lockdown
North Korea confirms first COVID-19 case ever, imposes nationwide lockdown World
COVID-19: India logs 2,927 new cases; 32 more deaths
COVID-19: India logs 2,927 new cases; 32 more deaths India
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years India
Government considering COVID-19 booster dose for all adults: Report
Government considering COVID-19 booster dose for all adults: Report India
COVID-19 vaccination for 12-14 years begins; here's how to register
COVID-19 vaccination for 12-14 years begins; here's how to register India
More News
Biological E
India: Phase-2 trials of world's first one-shot pneumococcal vaccine soon
India: Phase-2 trials of world's first one-shot pneumococcal vaccine soon India
Phase 2/3 trials of Corbevax on 5-18 age group permitted
Phase 2/3 trials of Corbevax on 5-18 age group permitted India
How Biological E's coronavirus vaccine could be a potential gamechanger
How Biological E's coronavirus vaccine could be a potential gamechanger India
India's neighbors train experts for clinical trials of COVID-19 vaccine
India's neighbors train experts for clinical trials of COVID-19 vaccine India
Modi to chair all-party meet to review COVID-19 situation Friday
Modi to chair all-party meet to review COVID-19 situation Friday India
More News
Related
Centre rules out mixing up of vaccines for 'precautionary' dose
Centre rules out mixing up of vaccines for 'precautionary' dose India
COVID-19 vaccine Corbevax's samples cleared by India's apex testing laboratory
COVID-19 vaccine Corbevax's samples cleared by India's apex testing laboratory India
Biological E-manufactured J&J's single-dose COVID-19 vaccine in India by October
Biological E-manufactured J&J's single-dose COVID-19 vaccine in India by October India
Moderna vaccine arriving in India in 2-3 days: Report
Moderna vaccine arriving in India in 2-3 days: Report India
Next News Article
Next News Article

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022